• IM/Cardiology

The research of Prediman K. Shah, MD, focuses on molecular mechanisms of atherosclerosis, and novel therapeutic strategies to prevent and reverse atherosclerosis.

• Internship: Mount Sinai Hospital, 1972
• Residency: Montefiore Medical Center, 1974
• Fellowship: Montefiore Medical Center, 1976

View CV as a PDF

• Smidt Heart Institute
• Aortic Program
• Department of Medicine
• General and Preventive Cardiology
• Preventive and Consultative Heart Center
• Cardiology
• Medicine

• Master of American College of Cardiology, 2015
• Elliot Rapaport Cardiologist of the Year, California-ACC, 2014
• Distinguished Scientific Achievement Award, American College of Cardiology, 2012
• Annual Laennec Society Lecture, American Heart Association, 2008
• James B Herrick Award, American Heart Association, 2008

• Sharifi BG, Zeng Z, Wang L, Song L, Chen H, Qin M, Sierra-Honigmann MR, Wachsmann-Hogiu S, Shah PK. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26(6):1273-1280.
• Wang L, Sharifi BG, Pan T, Song L, Yukht A, Shah PK. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice. J Am Coll Cardiol. 2006;48(7):1459-1468.
• Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U.S.A. 2004;101(29):10679-10684.